Coexpression cluster:C1426
From FANTOM5_SSTAR
Full id: C1426_CD14_bile_mucinous_lung_large_glioblastoma_nonsmall
Phase1 CAGE Peaks
Hg19::chr16:83986837..83986852,+ | p1@OSGIN1 |
Hg19::chr1:94374914..94374922,- | p7@GCLM |
Hg19::chr1:94374946..94374994,- | p1@GCLM |
Hg19::chr20:633833..633851,- | p1@SRXN1 |
Hg19::chr4:139092367..139092379,- | p@chr4:139092367..139092379 - |
Hg19::chr4:139163058..139163082,- | p8@SLC7A11 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
No results for this coexpression
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0006979 | response to oxidative stress | 0.00267447141343291 |
GO:0035226 | glutamate-cysteine ligase catalytic subunit binding | 0.00267447141343291 |
GO:0015327 | cystine:glutamate antiporter activity | 0.00267447141343291 |
GO:0035229 | positive regulation of glutamate-cysteine ligase activity | 0.00267447141343291 |
GO:0032542 | sulfiredoxin activity | 0.00267447141343291 |
GO:0035227 | regulation of glutamate-cysteine ligase activity | 0.00267447141343291 |
GO:0051409 | response to nitrosative stress | 0.00267447141343291 |
GO:0017109 | glutamate-cysteine ligase complex | 0.00416010516649996 |
GO:0004357 | glutamate-cysteine ligase activity | 0.00416010516649996 |
GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity | 0.00534823430200747 |
GO:0015184 | L-cystine transmembrane transporter activity | 0.00534823430200747 |
GO:0051900 | regulation of mitochondrial depolarization | 0.00534823430200747 |
GO:0000099 | sulfur amino acid transmembrane transporter activity | 0.00534823430200747 |
GO:0051351 | positive regulation of ligase activity | 0.00534823430200747 |
GO:0051882 | mitochondrial depolarization | 0.00623933116986053 |
GO:0051340 | regulation of ligase activity | 0.00660605893926391 |
GO:0006534 | cysteine metabolic process | 0.00660605893926391 |
GO:0005313 | L-glutamate transmembrane transporter activity | 0.0078802164471195 |
GO:0006750 | glutathione biosynthetic process | 0.0078802164471195 |
GO:0015172 | acidic amino acid transmembrane transporter activity | 0.00802058041895813 |
GO:0051899 | membrane depolarization | 0.00802058041895813 |
GO:0051881 | regulation of mitochondrial membrane potential | 0.00894971234644914 |
GO:0043524 | negative regulation of neuron apoptosis | 0.00894971234644914 |
GO:0005829 | cytosol | 0.0108478504797685 |
GO:0042221 | response to chemical stimulus | 0.0111896010626077 |
GO:0006536 | glutamate metabolic process | 0.0115131714638974 |
GO:0015175 | neutral amino acid transmembrane transporter activity | 0.0117791598889394 |
GO:0006749 | glutathione metabolic process | 0.0126936457064729 |
GO:0043523 | regulation of neuron apoptosis | 0.0161219563560019 |
GO:0016667 | oxidoreductase activity, acting on sulfur group of donors | 0.0169452130303383 |
GO:0005275 | amine transmembrane transporter activity | 0.0169452130303383 |
GO:0000096 | sulfur amino acid metabolic process | 0.0169452130303383 |
GO:0051402 | neuron apoptosis | 0.0169975821508008 |
GO:0042391 | regulation of membrane potential | 0.0170468221915915 |
GO:0015179 | L-amino acid transmembrane transporter activity | 0.0170932013623182 |
GO:0065008 | regulation of biological quality | 0.0200632651173214 |
GO:0035150 | regulation of tube size | 0.0206031839965857 |
GO:0050880 | regulation of blood vessel size | 0.0206031839965857 |
GO:0003018 | vascular process in circulatory system | 0.0206031839965857 |
GO:0044272 | sulfur compound biosynthetic process | 0.0210205779842032 |
GO:0009653 | anatomical structure morphogenesis | 0.0211854925063784 |
GO:0015300 | solute:solute antiporter activity | 0.0223308459100891 |
GO:0030308 | negative regulation of cell growth | 0.0223308459100891 |
GO:0045792 | negative regulation of cell size | 0.0223308459100891 |
GO:0048523 | negative regulation of cellular process | 0.0223308459100891 |
GO:0009069 | serine family amino acid metabolic process | 0.0223308459100891 |
GO:0048519 | negative regulation of biological process | 0.0230630761274883 |
GO:0045926 | negative regulation of growth | 0.0230630761274883 |
GO:0006950 | response to stress | 0.0230630761274883 |
GO:0015171 | amino acid transmembrane transporter activity | 0.0230630761274883 |
GO:0042493 | response to drug | 0.0230630761274883 |
GO:0006865 | amino acid transport | 0.0251250696915076 |
GO:0009064 | glutamine family amino acid metabolic process | 0.0284879107806133 |
GO:0035239 | tube morphogenesis | 0.0284879107806133 |
GO:0015837 | amine transport | 0.0284879107806133 |
GO:0006790 | sulfur metabolic process | 0.0286428388044346 |
GO:0015297 | antiporter activity | 0.029769822580319 |
GO:0046943 | carboxylic acid transmembrane transporter activity | 0.0302525219420084 |
GO:0046942 | carboxylic acid transport | 0.0302525219420084 |
GO:0015849 | organic acid transport | 0.0302525219420084 |
GO:0005342 | organic acid transmembrane transporter activity | 0.0302525219420084 |
GO:0016491 | oxidoreductase activity | 0.0303262360818528 |
GO:0046982 | protein heterodimerization activity | 0.0310591708125885 |
GO:0035295 | tube development | 0.0340499713122673 |
GO:0048869 | cellular developmental process | 0.0381580052831729 |
GO:0030154 | cell differentiation | 0.0381580052831729 |
GO:0008015 | blood circulation | 0.0436428645669278 |
GO:0003013 | circulatory system process | 0.0436428645669278 |
GO:0001558 | regulation of cell growth | 0.0436428645669278 |
GO:0048856 | anatomical structure development | 0.0438016778475504 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
animal cell | 1.09e-23 | 679 |
eukaryotic cell | 1.09e-23 | 679 |
epithelial cell | 2.56e-14 | 253 |
somatic cell | 4.76e-13 | 588 |
native cell | 1.18e-12 | 722 |
defensive cell | 1.08e-11 | 48 |
phagocyte | 1.08e-11 | 48 |
monopoietic cell | 1.19e-11 | 59 |
monocyte | 1.19e-11 | 59 |
monoblast | 1.19e-11 | 59 |
promonocyte | 1.19e-11 | 59 |
classical monocyte | 1.28e-11 | 42 |
CD14-positive, CD16-negative classical monocyte | 1.28e-11 | 42 |
mesodermal cell | 3.54e-11 | 121 |
myeloid lineage restricted progenitor cell | 7.46e-11 | 66 |
macrophage dendritic cell progenitor | 1.16e-10 | 61 |
embryonic cell | 2.93e-10 | 250 |
myeloid leukocyte | 1.01e-08 | 72 |
stuff accumulating cell | 1.12e-08 | 87 |
granulocyte monocyte progenitor cell | 1.32e-08 | 67 |
fibroblast | 1.96e-08 | 76 |
squamous epithelial cell | 6.73e-08 | 63 |
lining cell | 1.67e-07 | 58 |
barrier cell | 1.67e-07 | 58 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system | 2.05e-13 | 167 |
anatomical system | 2.83e-13 | 624 |
anatomical group | 4.31e-13 | 625 |
multi-cellular organism | 1.02e-12 | 656 |
mesoderm | 7.51e-12 | 315 |
mesoderm-derived structure | 7.51e-12 | 315 |
presumptive mesoderm | 7.51e-12 | 315 |
trunk | 7.44e-10 | 199 |
skeletal system | 2.32e-09 | 100 |
epithelial tube | 2.91e-09 | 117 |
organism subdivision | 3.20e-09 | 264 |
skeletal element | 3.74e-09 | 90 |
bone marrow | 1.55e-08 | 76 |
unilaminar epithelium | 3.42e-08 | 148 |
bone element | 3.65e-08 | 82 |
artery | 4.21e-08 | 42 |
arterial blood vessel | 4.21e-08 | 42 |
arterial system | 4.21e-08 | 42 |
organ | 1.27e-07 | 503 |
lateral plate mesoderm | 1.27e-07 | 203 |
developing anatomical structure | 1.73e-07 | 581 |
vessel | 6.17e-07 | 68 |
embryo | 6.28e-07 | 592 |
mesenchyme | 8.71e-07 | 160 |
entire embryonic mesenchyme | 8.71e-07 | 160 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)
TF | #promoters | Enrichment | p-value | q-value |
---|---|---|---|---|
BCLAF1#9774 | 3 | 10.8263238050609 | 0.00177235104699106 | 0.0108896676665902 |
CCNT2#905 | 4 | 4.22413438464176 | 0.00710980547887581 | 0.0296116196525886 |
CTCF#10664 | 4 | 3.57350424871668 | 0.0131663500723851 | 0.0466049969567812 |
CTCFL#140690 | 3 | 9.87323717948718 | 0.00231276002785771 | 0.0131187456305361 |
E2F1#1869 | 5 | 4.08949101239944 | 0.00174981759776199 | 0.0107588131456885 |
E2F4#1874 | 3 | 6.33403015764222 | 0.00819717536837434 | 0.0323620170219115 |
E2F6#1876 | 5 | 4.18096310974782 | 0.00157359875958697 | 0.0099748167548254 |
EGR1#1958 | 5 | 4.15681591234178 | 0.00161796681886444 | 0.010133663364041 |
ELF1#1997 | 5 | 3.54841496567295 | 0.00344683777572169 | 0.0175311332647608 |
FOS#2353 | 4 | 5.99863687259627 | 0.00189982371188635 | 0.0111840194265091 |
FOSL1#8061 | 3 | 19.8567898581865 | 0.000301402757252219 | 0.00311049432457159 |
GTF2B#2959 | 3 | 15.9719149671621 | 0.000571165371589299 | 0.00486716222612719 |
HDAC2#3066 | 4 | 8.9437468244175 | 0.000409407956530718 | 0.00390307234797915 |
HEY1#23462 | 5 | 3.36675920258809 | 0.00442382704520303 | 0.0209504408821457 |
HNF4A#3172 | 3 | 11.5661451814768 | 0.00146348715008573 | 0.00937700211458919 |
JUN#3725 | 3 | 6.25641459616817 | 0.00848634685095487 | 0.0324143502456525 |
JUND#3727 | 4 | 4.66310929458068 | 0.00491764340826023 | 0.0229919312344566 |
MAFF#23764 | 4 | 37.5435709932968 | 1.44675523683818e-06 | 5.6232850829975e-05 |
MAFK#7975 | 4 | 18.0671554252199 | 2.61700332070418e-05 | 0.000564238666001288 |
NFE2#4778 | 3 | 38.6021303258145 | 4.21574363639564e-05 | 0.000754822646393835 |
REST#5978 | 4 | 6.43335247741868 | 0.00145495422303207 | 0.00932518957344256 |
SIN3A#25942 | 5 | 4.50740393901261 | 0.00109611006120864 | 0.00766088728384988 |
SMC3#9126 | 3 | 7.52246642246642 | 0.00503954071682855 | 0.0234819573893485 |
STAT1#6772 | 3 | 10.3532937485996 | 0.00201668045992093 | 0.0117219551732904 |
STAT2#6773 | 2 | 21.7545903954802 | 0.00337914239989322 | 0.0172557330873483 |
STAT3#6774 | 3 | 5.25973249857712 | 0.0137766205807855 | 0.048471111603445 |
TAF1#6872 | 5 | 2.78587190478774 | 0.0107863634029041 | 0.039792193833836 |
TAF7#6879 | 3 | 5.71653470246196 | 0.0109272937988966 | 0.04021267220095 |
TBP#6908 | 5 | 3.08897557258032 | 0.00664544827578693 | 0.0282879141012803 |
TCF7L2#6934 | 4 | 7.18011770875823 | 0.000955329712067973 | 0.00687572736535504 |
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.